Get started
Author

Naoyuki Okabe

Observed names: N. Okabe, NAOYUKI OKABE
ORCID: 0000-0002-1037-9507
Observed ORCID: 0000-0002-1037-9507
OpenAlex ID: A5043214677
Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report
2018 · Yuki Owada-Ozaki, Satoshi Muto, et al. · Journal of Thoracic Oncology · 170
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
2013 · Hiroyuki Suzuki, Mitsuro Fukuhara, et al. · Journal of Translational Medicine · 78
PDF
An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids
2019 · Nobuhiko Takahashi, Hirotaka Hoshi, et al. · Cells · 76
PDF
Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
2023 · Satoshi Muto, Akio Enta, et al. · Biomedicines · 66
PDF
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer
2015 · Jun Osugi, Takumi Yamaura, et al. · Lung Cancer · 64
FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma
2015 · NAOYUKI OKABE, JUNJI EZAKI, et al. · International Journal of Oncology · 50
PDF
Prognostic value of peripheral and local forkhead box P3+ regulatory T cells in patients with non-small-cell lung cancer
2014 · TAKEO HASEGAWA, HIROYUKI SUZUKI, et al. · Molecular and Clinical Oncology · 50
PDF
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer
2019 · Yuki Ozaki, Satoshi Muto, et al. · Cancer Immunology Immunotherapy · 44
PDF
Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature
2019 · Takeo Hasegawa, Yuki Ozaki, et al. · Journal of Medical Case Reports · 42
PDF
The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study
2021 · Mitsuro Fukuhara, Satoshi Muto, et al. · Cancer Immunology Immunotherapy · 37
Prognostic Impact of Hypoxia-InduciblemiRNA-210in Patients with Lung Adenocarcinoma
2015 · Jun Osugi, Yuka Kimura, et al. · Journal of Oncology · 34
PDF
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer
2019 · Wungki Park, Laura Mezquita, et al. · British Journal of Cancer · 30
PDF
Tumor β‑catenin expression is associated with immune evasion in non‑small cell lung cancer with high tumor mutation burden
2021 · Satoshi Muto, Yuki Ozaki, et al. · Oncology Letters · 24
PDF
Clinical significance of expanded Foxp3+ Helios− regulatory T cells in patients with non-small cell lung cancer
2015 · SATOSHI MUTO, YUKI OWADA, et al. · International Journal of Oncology · 24
PDF
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)
2021 · Hironori Takagi, Songji Zhao, et al. · Lung Cancer · 23
PDF
The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
2017 · Takuya Inoue, Hironori Takagi, et al. · Trials · 21
PDF
CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma
2021 · Masayuki Watanabe, Tomohito Higashi, et al. · Scientific Reports · 19
PDF
Construction of in vitro patient‑derived tumor models to evaluate anticancer agents and cancer immunotherapy
2021 · Nobuhiko Takahashi, Arisa Higa, et al. · Oncology Letters · 17
PDF
Recent advances in immunotherapy for non-small-cell lung cancer
2013 · Hiroyuki Suzuki, Yuki Owada, et al. · Human Vaccines & Immunotherapeutics · 17
PDF
Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination
2018 · Kazuyoshi Takeda, Kazutaka Kitaura, et al. · Cancer Immunology Immunotherapy · 15
Recurrent Intrapulmonary Solitary Fibrous Tumor With Malignant Transformation
2016 · Takuya Inoue, Yuki Owada, et al. · The Annals of Thoracic Surgery · 15
Garcin syndrome caused by sphenoid bone metastasis of lung cancer: a case study
2018 · Satoshi Fukai, Naoyuki Okabe, et al. · World Journal of Surgical Oncology · 14
PDF
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma
2017 · Naoyuki Okabe, Hironori Takagi, et al. · Journal of Thoracic Oncology · 14
PDF
Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients
2017 · SATOSHI MUTO, HIRONORI TAKAGI, et al. · Anticancer Research · 14
PDF
Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons
2017 · Mitsunori Higuchi, Hironori Takagi, et al. · Oncology Letters · 14
Works count: 96
Citation count: 1,107
H-index: 17
I10-index: 27
Year
Topic
Type